ThermoGenesis Holdings, Inc.

OTCPK:THMO Stok Raporu

Piyasa değeri: US$7.9k

ThermoGenesis Holdings Yönetim

Yönetim kriter kontrolleri 3/4

Şu anda CEO hakkında yeterli bilgiye sahip değiliz.

Anahtar bilgiler

Chris Xu

İcra Kurulu Başkanı

US$520.0k

Toplam tazminat

CEO maaş yüzdesi100.0%
CEO görev süresi8yrs
CEO sahipliğin/a
Yönetim ortalama görev süresiVeri yok
Yönetim Kurulu ortalama görev süresi8.7yrs

Son yönetim güncellemeleri

Recent updates

It's Down 52% But ThermoGenesis Holdings, Inc. (NASDAQ:THMO) Could Be Riskier Than It Looks

Apr 17
It's Down 52% But ThermoGenesis Holdings, Inc. (NASDAQ:THMO) Could Be Riskier Than It Looks

ThermoGenesis reports Q2 results

Aug 11

Is ThermoGenesis Holdings (NASDAQ:THMO) Using Too Much Debt?

Oct 20
Is ThermoGenesis Holdings (NASDAQ:THMO) Using Too Much Debt?

Is ThermoGenesis Holdings (NASDAQ:THMO) A Risky Investment?

May 31
Is ThermoGenesis Holdings (NASDAQ:THMO) A Risky Investment?

When Will ThermoGenesis Holdings, Inc. (NASDAQ:THMO) Become Profitable?

Apr 06
When Will ThermoGenesis Holdings, Inc. (NASDAQ:THMO) Become Profitable?

Here's Why ThermoGenesis Holdings (NASDAQ:THMO) Can Afford Some Debt

Feb 10
Here's Why ThermoGenesis Holdings (NASDAQ:THMO) Can Afford Some Debt

Does ThermoGenesis Holdings' (NASDAQ:THMO) CEO Salary Compare Well With Industry Peers?

Dec 15
Does ThermoGenesis Holdings' (NASDAQ:THMO) CEO Salary Compare Well With Industry Peers?

ThermoGenesis EPS misses by $0.27, misses on revenue

Nov 12

CEO Tazminat Analizi

Chris Xu'un ücretlendirmesi ThermoGenesis Holdings'un kazancına kıyasla nasıl değişti?
TarihToplam TazminatMaaşŞirket Kazançları
Mar 31 2024n/an/a

-US$15m

Dec 31 2023US$520kUS$520k

-US$18m

Sep 30 2023n/an/a

-US$14m

Jun 30 2023n/an/a

-US$14m

Mar 31 2023n/an/a

-US$14m

Dec 31 2022US$699kUS$519k

-US$11m

Sep 30 2022n/an/a

-US$10m

Jun 30 2022n/an/a

-US$9m

Mar 31 2022n/an/a

-US$11m

Dec 31 2021US$748kUS$500k

-US$11m

Sep 30 2021n/an/a

-US$12m

Jun 30 2021n/an/a

-US$12m

Mar 31 2021n/an/a

-US$14m

Dec 31 2020US$2mUS$505k

-US$16m

Sep 30 2020n/an/a

-US$18m

Jun 30 2020n/an/a

-US$17m

Mar 31 2020n/an/a

-US$12m

Dec 31 2019US$472kUS$472k

-US$9m

Sep 30 2019n/an/a

-US$13m

Jun 30 2019n/an/a

-US$13m

Mar 31 2019n/an/a

-US$39m

Dec 31 2018US$653kUS$460k

-US$40m

Sep 30 2018n/an/a

-US$32m

Jun 30 2018n/an/a

-US$32m

Mar 31 2018n/an/a

-US$6m

Dec 31 2017US$1mUS$216k

-US$6m

Tazminat ve Piyasa: Chris 'ın toplam tazminatı ($USD 520.00K ) US pazarındaki benzer büyüklükteki şirketler için ortalamadır ($USD 642.87K ).

Tazminat ve Kazançlar: Chris 'in tazminatı, şirketin son bir yıldaki performansıyla tutarlıydı.

CEO

Chris Xu (53 yo)

8yrs

Görev süresi

US$520,000

Tazminat

Dr. Xiaochun Xu, also known as Chris, M.B.A. Ph D., serves as Chief Executive Officer and Chairman at ImmuneCyte Life Sciences, Inc. Dr. Xu is the Founder, Chairman and Chief Executive Officer of Boyalife...

Yönetim Kurulu Üyeleri

İsimPozisyonGörev süresiTazminatSahiplik
Xiaochun Xu
Chairman of the Board & CEO8.7yrsUS$520.00kVeri yok
Solomon Hamburg
Member of Clinical & Scientific Advisory Board10.5yrsVeri yokVeri yok
Lars Norgren
Member of Clinical Advisory Board8.7yrsVeri yokVeri yok
Biao Xi
Independent Director1.3yrsUS$10.00kVeri yok

8.7yrs

Ortalama Görev Süresi

Deneyimli Yönetim Kurulu: THMO 'nin yönetim kurulu üyeleri deneyimli olarak kabul edilir (ortalama görev süresi 8.7 yıldır).